Clinical Trials Directory

Trials / Completed

CompletedNCT00330941

Intravenous Lidocaine and Acute Rehabilitation

Intravenous Lidocaine Infusion Improves Outcome After Laparoscopic Colectomy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
45 (planned)
Sponsor
The Cleveland Clinic · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Background: Intravenous infusion of lidocaine may decrease postoperative pain and speed return of bowel function. The investigators therefore tested the hypothesis that including perioperative lidocaine infusion improves recovery from laparoscopic colectomy and shortens the duration of hospitalization. Methods: Forty patients scheduled for laparoscopic colectomy were randomly allocated to receive intravenous lidocaine (bolus injection of 1.5 mg.kg-1 lidocaine at induction of anesthesia, then a continuous infusion of 2 mg.kg-1.h-1 intraoperatively and 1.33 mg.kg-1.h-1 for 24 h postoperatively) or an equal volume of saline. All patients received similar intensive postoperative rehabilitation. Postoperative pain scores, opioid consumption, and fatigue scores were measured. Times to first flatus, defecation, and hospital discharge were recorded. Postoperative endocrine (cortisol and catecholamines) and metabolic (leucocytes, C-reactive protein, and glucose) responses were measured for 48 h. Data (median \[25%-75% interquartile range\] Saline vs Lidocaine groups) were analyzed using Mann-Whitney tests. P\<0.05 was considered statistically significant.

Conditions

Interventions

TypeNameDescription
DRUGlidocaine

Timeline

Start date
2003-01-01
Completion
2004-12-01
First posted
2006-05-29
Last updated
2023-04-13

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT00330941. Inclusion in this directory is not an endorsement.

Intravenous Lidocaine and Acute Rehabilitation (NCT00330941) · Clinical Trials Directory